BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11955796)

  • 1. IGF-1 in gynaecology and obstetrics: update 2002.
    Druckmann R; Rohr UD
    Maturitas; 2002 Apr; 41 Suppl 1():S65-83. PubMed ID: 11955796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration in vitro.
    Piltonen TT; Chen JC; Khatun M; Kangasniemi M; Liakka A; Spitzer T; Tran N; Huddleston H; Irwin JC; Giudice LC
    Hum Reprod; 2015 May; 30(5):1203-15. PubMed ID: 25750105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery.
    Rutanen EM
    Hum Reprod; 2000 Aug; 15 Suppl 3():173-81. PubMed ID: 11041233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
    Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
    Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
    Giudice LC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.
    Ayabe T; Tsutsumi O; Sakai H; Yoshikawa H; Yano T; Kurimoto F; Taketani Y
    Endocr J; 1997 Jun; 44(3):419-24. PubMed ID: 9279518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator and insulin-like growth factor-binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: implications for the pathophysiology of endometriosis.
    Lembessis P; Milingos S; Michalas S; Milingos D; Creatsas G; Sourla A; Koutsilieris M
    Ann N Y Acad Sci; 2003 Nov; 997():223-8. PubMed ID: 14644829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
    Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
    Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
    Schoyer KD; Liu HC; Witkin S; Rosenwaks Z; Spandorfer SD
    Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis.
    Giudice LC; Dsupin BA; Gargosky SE; Rosenfeld RG; Irwin JC
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1284-93. PubMed ID: 7525631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion.
    Irwin JC; de las Fuentes L; Dsupin BA; Giudice LC
    Regul Pept; 1993 Oct; 48(1-2):165-77. PubMed ID: 7505463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
    Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
    Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
    Giovannucci E
    Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of in vitro fertilization outcome with circulating insulin-like growth factor components prior to cycle initiation.
    Ramer I; Kanninen TT; Sisti G; Witkin SS; Spandorfer SD
    Am J Obstet Gynecol; 2015 Sep; 213(3):356.e1-6. PubMed ID: 25935785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.